GTEx Pituitary 20-29 vs 50-59 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Pituitary 20-29 vs 50-59 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Pituitary 20-29 vs 50-59 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Pituitary 20-29 vs 50-59 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Pituitary 20-29 vs 50-59 Down.

Results found

Linked to

 

Label

Description

 

Gene

brain cytoplasmic RNA 1

Gene

long intergenic non-protein coding RNA 1224

Gene

MT-ND4 pseudogene 12

Gene

APCDD1L divergent transcript

Gene

MT-CO1 pseudogene 12

Gene

ribosomal protein SA pseudogene 52

Gene

FOXF1 adjacent non-coding developmental regulatory RNA

Gene

MT-ND1 pseudogene 23

Gene

long intergenic non-protein coding RNA 648

Gene

uncharacterized LOC102724843

  • Gene

    brain cytoplasmic RNA 1


  • Gene

    long intergenic non-protein coding RNA 1224


  • Gene

    MT-ND4 pseudogene 12


  • Gene

    APCDD1L divergent transcript


  • Gene

    MT-CO1 pseudogene 12


  • Gene

    ribosomal protein SA pseudogene 52


  • Gene

    FOXF1 adjacent non-coding developmental regulatory RNA


  • Gene

    MT-ND1 pseudogene 23


  • Gene

    long intergenic non-protein coding RNA 648


  • Gene

    uncharacterized LOC102724843

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.